BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reyes-Madrigal F, León-Ortiz P, Mao X, Mora-Durán R, Shungu DC, de la Fuente-Sandoval C. Striatal Glutathione in First-episode Psychosis Patients Measured In Vivo with Proton Magnetic Resonance Spectroscopy. Arch Med Res 2019;50:207-13. [PMID: 31499481 DOI: 10.1016/j.arcmed.2019.08.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Goh XX, Tang PY, Tee SF. Effects of antipsychotics on antioxidant defence system in patients with schizophrenia: A meta-analysis. Psychiatry Res 2022;309:114429. [PMID: 35150976 DOI: 10.1016/j.psychres.2022.114429] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Zhu X, Cabungcal JH, Cuenod M, Uliana DL, Do KQ, Grace AA. Thalamic reticular nucleus impairments and abnormal prefrontal control of dopamine system in a developmental model of schizophrenia: prevention by N-acetylcysteine. Mol Psychiatry 2021;26:7679-89. [PMID: 34193975 DOI: 10.1038/s41380-021-01198-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
3 Bottino F, Lucignani M, Napolitano A, Dellepiane F, Visconti E, Rossi Espagnet MC, Pasquini L. In Vivo Brain GSH: MRS Methods and Clinical Applications. Antioxidants (Basel) 2021;10:1407. [PMID: 34573039 DOI: 10.3390/antiox10091407] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
4 Jeon P, Limongi R, Ford SD, Branco C, Mackinley M, Gupta M, Powe L, Théberge J, Palaniyappan L. Glutathione as a Molecular Marker of Functional Impairment in Patients with At-Risk Mental State: 7-Tesla 1H-MRS Study. Brain Sci 2021;11:941. [PMID: 34356175 DOI: 10.3390/brainsci11070941] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Cruz BF, de Campos-Carli SM, de Oliveira AM, de Brito CB, Garcia ZM, do Nascimento Arifa RD, de Souza DDG, Teixeira AL, Salgado JV. Investigating potential associations between neurocognition/social cognition and oxidative stress in schizophrenia. Psychiatry Res 2021;298:113832. [PMID: 33652247 DOI: 10.1016/j.psychres.2021.113832] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Perkins DO, Jeffries CD, Do KQ. Potential Roles of Redox Dysregulation in the Development of Schizophrenia. Biol Psychiatry 2020;88:326-36. [PMID: 32560962 DOI: 10.1016/j.biopsych.2020.03.016] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 15.0] [Reference Citation Analysis]